Most patients see significant changes within the first month when following an appropriate diet plan
A spokesperson for the company noted that gastroparesis is a known risk for people with diabetes and that "patient safety is of utmost importance to Novo Nordisk." Gastroparesis is not mentioned in the prescribing information for Ozempic or Wegovy, but delayed gastric emptying is mentioned for each drug
Patients should seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or symptoms of severe hypoglycemia after consuming alcohol
Supplements that influence blood sugar, including chromium, berberine, and high-dose cinnamon, can amplify semaglutide's glucose-lowering effect
Traveling on a stable, well-tolerated dose is much easier than traveling during an adjustment period